Diabetes

Experimental compound counters diabetic complications

An experimental compound reduced complications of type 1 and type 2 diabetes in mice—not by lowering blood sugar—but by countering its consequences: cell death, inflammation, and organ damage.

Diseases, Conditions, Syndromes

Solution sought to 'sticky' staph situation

David Heinrichs faces a potentially deadly adversary found on the skin of almost 30 per cent of the population – and the battle just got a whole lot stickier.

Neuroscience

An antibody-based drug for multiple sclerosis

Inserm Unit U919, directed by Prof. Denis Vivien ("Serine Proteases and Physiopathology of the Neurovascular Unit") has developed an antibody with potential therapeutic effects against multiple sclerosis. The study, directed ...

Neuroscience

Gut microbiome influences ALS outcomes

Harvard University scientists have identified a new gut-brain connection in the neurodegenerative disease amyotrophic lateral sclerosis, or ALS. The researchers found that in mice with a common ALS genetic mutation, changing ...

page 9 from 40